Page 22 - வர்த்தகம் தொடர்புடையது அறிவுசார் ப்ராபர்டீ உரிமைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

outlookindia.com 2021-01-17T11:42:25+05:30 Around 2005, India turned into a favoured destination for foreign pharma companies to carry out human clinical trials for new medicines, vaccines and other treatments. Two things changed amendments in the patent law and clinical trial rules. From 2005 onw­ard, clinical trials in India registered an exponential inc­rease from 180 to 506 in 2010. The Indian patent law was amended from ‘process patent’ to ‘product patent’ in January 2005 to comply with the World Trade Organisation’s Trade-Related Intellectual Property Rights (TRIPS) provisions. Under the process patent, Indian pharma companies had their own ways of manufacturing medicines developed by western pharma companies. Introduction of product patent stopped this manipulation and forced Indian firms to collaborate with western companies.

World trade organisationTrade related intellectual property rightsCovid 19Covid vaccineClinical trialClinical trial normsCovid clinical trial volunteerCovid immunityPharma companyHuman clinical trial for covid vaccinesClinical trial rulesIndian patent lawஉலகம் வர்த்தகம் ஆர்கநைஸேஶந்வர்த்தகம் தொடர்புடையது அறிவுசார் ப்ராபர்டீ உரிமைகள்மருத்துவ சோதனைமருத்துவ சோதனை நியமங்கள்